Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.8900
+0.0300 (1.61%)
NASDAQ · Last Trade: Apr 30th, 9:08 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors